Website stats and analysis
adsense unsafe advertisement

We combined forces with the brightest minds in the field to radically change the way research is done – to save lives faster.

unsafe advertisement
2.48 Rating by Usitestat

parkerici.org was registered 8 years 7 months ago. It has a alexa rank of #211,965 in the world. It is a domain having .org extension. It is estimated worth of $ 43,740.00 and have a daily income of around $ 81.00. As no active threats were reported recently, parkerici.org is SAFE to browse.

Traffic Report

Daily Unique Visitors: 7,239
Daily Pageviews: 28,956

Estimated Valuation

Income Per Day: $ 81.00
Estimated Worth: $ 43,740.00

Search Engine Indexes

Google Indexed Pages: Not Applicable
Yahoo Indexed Pages: Not Applicable
Bing Indexed Pages: Not Applicable

Search Engine Backlinks

Google Backlinks: Not Applicable
Bing Backlinks: Not Applicable
Alexa BackLinks: Not Applicable

Safety Information

Google Safe Browsing: No Risk Issues
Siteadvisor Rating: Not Applicable
WOT Trustworthiness: Very Poor
WOT Privacy: Very Poor
WOT Child Safety: Very Poor

Website Ranks & Scores

Alexa Rank: 211,965
PageSpeed Score: 45 ON 100
Domain Authority: 49 ON 100
Bounce Rate: Not Applicable
Time On Site: Not Applicable

Web Server Information

Hosted IP Address:

69.167.160.75

Hosted Country:

United States US

Location Latitude:

42.7333

Location Longitude:

-84.6378
unsafe advertisement

Traffic Classification

Total Traffic: No Data
Direct Traffic: No Data
Referral Traffic: No Data
Search Traffic: No Data
Social Traffic: No Data
Mail Traffic: No Data
Display Traffic: No Data

Search Engine Results For parkerici.org

Parker Institute for Cancer Immunotherapy

- https://www.parkerici.org/

The Parker Institute for Cancer Immunotherapy coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry.


Login | PICI

- https://members.parkerici.org/login

Member Center. Welcome to the Parker Institute for Cancer Immunotherapy. The PICI Member Center's tools and resources enable participating researchers to connect, communicate...


Introduction - Mantis Viewer

- https://mantis.parkerici.org/

Overview . Mantis Viewer is an application developed by the Parker Institute for Cancer Immunotherapy for viewing and analyzing multi-channel pathology imaging, such as IHC,...


Donate to Parker Institute for Cancer Immunotherapy

- https://donate.parkerici.org/give/264029/#!/donation/checkout

The Parker Institute for Cancer Immunotherapy's mission is to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases.


Importing Data - Mantis Viewer - mantis.parkerici.org

- https://mantis.parkerici.org/importing_data/

Overview . Mantis Viewer supports importing from a variety of data formats. The import functionality of Mantis can be accessed from the main menu in the Import submenu.


GitHub - ParkerICI/tesla: Repository for published code ...

- https://github.com/ParkerICI/tesla

GitHub is where the world builds software. Millions of developers and companies build, ship, and maintain their software on GitHub — the largest and most advanced development...


Parker Institute for Cancer Immunotherapy · GitHub

- https://github.com/ParkerICI

Parker Institute for Cancer Immunotherapy has 27 repositories available. Follow their code on GitHub.


Home - The Parker Foundation

- https://parker.org/

Jun 19, 2017 · The Parker Foundation seeks transformative answers to the biggest problems—to either solve them once and for all, or to make them manageable in a significant way.


The priming power of cDC2s - ACIR (en-US)

- https://acir.org/weekly-digests/2019/april/the-priming-power-of-cdc2s

Apr 24, 2019 · In tumor-bearing mice, populations of migratory cDC2s induced CD4+ T cell proliferation, but were defective in inducing differentiation or antitumor immunity....


Overview - COVID-19 Data Resources

- https://covid-19.parkerici.org/

PICI Data Resources on COVID-19 . SARS-CoV-2 (COVID-19) is an ongoing worldwide viral pandemic. To help accelerate research in this area, the Parker Institute for Cancer...


Immunotherapy News - BMS, Parker Institute, and Cancer ...

- https://www.cancerresearch.org/news/2017/parker-institute-for-cancer-immunotherapy-bristol

For more information, visit parkerici.org. About the Cancer Research Institute The Cancer Research Institute (CRI), established in 1953, is the world’s leading nonprofit...


CureSearch Teams Up with Parker Institute for Cancer ...

- https://curesearch.org/CureSearch-Teams-Up-with-Parker-Institute-for-Cancer-Immunotherapy-to-Launch-New-Collaboration

Parker Institute for Cancer Immunotherapy: Anna Prince, [email protected]. Back to Blog & Press Releases. About This Blog. A blog about children's cancer survivors, fighters...


Curriculum Vitae Parker Institute for Cancer Immunotherapy

- https://www.fda.gov/media/119968/download

Revised 12/20/2018 2 . 2008-2010 Director of Operations, UPCI Immunologic Monitoring and Cellular Products Laboratory . 2010-2013 Associate Professor of Medicine, Surgery an d...


Key Parameters of Tumor Epitope Immunogenicity Revealed ...

- https://pubmed.ncbi.nlm.nih.gov/33038342/

Affiliations 1 Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. Electronic address: [email protected]. 2 Division of Molecular Oncology and Immunology, the...


Powerful new cancer drugs can trigger diabetes — and no ...

- https://www.statnews.com/2019/05/29/a-lifesaver-with-a-catch-powerful-new-cancer-drugs-can-trigger-diabetes-and-no-one-is-certain-why/

May 29, 2019 · A small number of patients on immunotherapy drugs experience the same irreversible side effect. Making matters worse, oncologists have little clue why.


Sean Parker is nerding out on cancer research. And he’s ...

- https://www.statnews.com/2019/07/09/sean-parker-cancer-research-science/

Jul 09, 2019 · And so Sharma, who herself is a pathbreaking immunologist, made sure to be home that afternoon. Sure enough, two men showed up in a van they …


TESLA Initiative Discovers Keys That Could Unlock Better ...

- https://www.cancerresearch.org/news/2020/pici-cri-tesla-neoantigen-parameters-cell-press

Find out more at www.parkerici.org. About Cancer Research Institute. The Cancer Research Institute (CRI), established in 1953, is a highly-rated U.S. nonprofit organization...


Multiple antigen-engineered DC vaccines with or without ...

- https://pubmed.ncbi.nlm.nih.gov/31014399/

Background: Cancer vaccines are designed to promote systemic antitumor immunity and tumor eradication. Cancer vaccination may be more efficacious in combination with additional...


Napster founder Sean Parker announces $250 million grant ...

- https://money.cnn.com/2016/04/13/technology/sean-parker-donation-cancer-immunotherapy/index.html

Apr 13, 2016 · The man whose file-sharing service terrorized the music industry is injecting $250 million into the fight against cancer. Silicon Valley billionaire Sean Parker...


'Encouraging' Antitumor Activity in Pancreatic Ca With ...

- https://www.medpagetoday.com/meetingcoverage/aacr/78978

Apr 02, 2019 · Meeting Coverage > AACR 'Encouraging' Antitumor Activity in Pancreatic Ca With CD40 Agonist — Early trial found 92% disease control rate in difficult-to-treat...

Page Resources Breakdown

Homepage Links Analysis

Parker Institute for Cancer Immunotherapy
We combined forces with the brightest minds in the field to radically change the way research is done – and save lives faster.

Website Inpage Analysis

H1 Headings: 2 H2 Headings: 18
H3 Headings: 1 H4 Headings: Not Applicable
H5 Headings: Not Applicable H6 Headings: Not Applicable
Total IFRAMEs: Not Applicable Total Images: 27
Google Adsense: Not Applicable Google Analytics: Not Applicable

Two Phrase Analysis

Words Occurrences Density Possible Spam
Cancer Research 4 0.772 % No
For Media 3 0.579 % No
and nonprofit 3 0.579 % No
Research Projects 3 0.579 % No
Strategic Partnerships 3 0.579 % No
Projects Clinical 3 0.579 % No
the field 3 0.579 % No
Research Heroes 3 0.579 % No
in the 3 0.579 % No
On Prostate 2 0.386 % No
PICI Takes 2 0.386 % No
Takes On 2 0.386 % No
Pancreatic Clinical 2 0.386 % No
Prostate Cancer 2 0.386 % No
Vision Develop 2 0.386 % No
immune therapies 2 0.386 % No
therapies to 2 0.386 % No
breakthrough immune 2 0.386 % No
Develop breakthrough 2 0.386 % No
About Mission 2 0.386 % No

Four Phrase Analysis

Words Occurrences Density Possible Spam
An Insider View of 2 0.386 % No
Insider View of PICI’s 2 0.386 % No
PICI Catalyzes Scientific Innovation 2 0.386 % No
Media Resources for Press 2 0.386 % No
News For Media Resources 2 0.386 % No
For Media Resources for 2 0.386 % No
View of PICI’s Pancreatic 2 0.386 % No
of PICI’s Pancreatic Clinical 2 0.386 % No
Vision Develop breakthrough immune 2 0.386 % No
Develop breakthrough immune therapies 2 0.386 % No
Mission Vision Develop breakthrough 2 0.386 % No
About Mission Vision Develop 2 0.386 % No
PICI Takes On Prostate 2 0.386 % No
Takes On Prostate Cancer 2 0.386 % No
the News For Media 2 0.386 % No
in the News For 2 0.386 % No
News News Menu The 2 0.386 % No
News Menu The Latest 2 0.386 % No
immunotherapy News News Menu 2 0.386 % No
cancer immunotherapy News News 2 0.386 % No

Mobile Friendly Check


Mobile Friendly : Yes
Score : 99

Mobile viewport not set: 0
Text too small to read: 0
Uses incompatible plugins: 0
Content wider than screen: 0
Links too close together: 0.013580805794477
CMS: WORDPRESS
Locale: en_US
Roboted Resources: 0
Transient Fetch Failure Resources: 5

HTTP Header Analysis

Http-Version: 1.1
Status-Code: 200
Status: 200 OK
Date: Sun, 26 Jan 2020 22:21:32 GMT
Server: Apache
Vary: Accept-Encoding,User-Agent
Last-Modified: Sun, 26 Jan 2020 04:11:48 GMT
Accept-Ranges: bytes
Content-Length: 29423
Cache-Control: max-age=0
Expires: Sun, 26 Jan 2020 22:21:32 GMT
Content-Type: text/html; charset=UTF-8
Content-Encoding: gzip

Domain Information

Domain Registrar: Public Interest Registry
Registration Date: 2015-11-07 8 years 7 months 2 weeks ago

Domain Nameserver Information

Host IP Address Country
ns1dns.name.com 163.114.216.17 France France
ns2glx.name.com 163.114.216.49 France France
ns4lrt.name.com 163.114.217.49 France France
ns3jwx.name.com 163.114.217.17 France France

DNS Record Analysis

Host Type TTL Extra
parkerici.org A 247 IP: 69.167.160.75
parkerici.org NS 300 Target: ns3jwx.name.com
parkerici.org NS 300 Target: ns4lrt.name.com
parkerici.org NS 300 Target: ns1dns.name.com
parkerici.org NS 300 Target: ns2glx.name.com
parkerici.org SOA 300 MNAME: ns1dns.name.com
RNAME: support.name.com
Serial: 1579826019
Refresh: 10800
Retry: 3600
Expire: 604800
parkerici.org MX 300 Priority: 1
Target: ASPMX.L.GOOGLE.com
parkerici.org MX 300 Priority: 10
Target: ALT4.ASPMX.L.GOOGLE.com
parkerici.org MX 300 Priority: 10
Target: ALT3.ASPMX.L.GOOGLE.com
parkerici.org MX 300 Priority: 5
Target: ALT2.ASPMX.L.GOOGLE.com
parkerici.org MX 300 Priority: 5
Target: ALT1.ASPMX.L.GOOGLE.com
parkerici.org TXT 300 TXT: ZOOM_verify_N_qPbTUnSI2bvWtaTcRwdg
parkerici.org TXT 300 TXT:
atlassian-domain-verification=gSd5aCSAx6
Vxp7PCCZ2JH2yRXvm+VE66jmCv2cajmrBKgos8aQ
b3p4/i8YhTfp6T
parkerici.org TXT 300 TXT: v=spf1 include:_spf.google.com
include:_spf.atlassian.net
include:servers.mcsv.net ~all
parkerici.org TXT 300 TXT:
W4NVIDF7YMCF8D9NO8TEYRKFD2DJHFI7TY8CMOS7
P
parkerici.org TXT 300 TXT:
logmein-verification-code=05b73bb2-7c75-
439e-bed2-89e61de9372c
parkerici.org TXT 300 TXT:
_globalsign-domain-verification=NR92xlpE
cwennVlU-6z8Aei2jSkN46yV1M5jtnu4yu
parkerici.org TXT 300 TXT:
docusign=03fa0e8d-d1f7-4414-9c33-704237f
8d3de
parkerici.org TXT 300 TXT:
atlassian-domain-verification=1YPXOyvjqy
73bBFixYt0C9ikHQkYNPec7dbJ6ZMhUqEIjMre7/
UcY3qCFvgPzKrd
parkerici.org TXT 300 TXT: MS=ms53014560
parkerici.org TXT 300 TXT:
_globalsign-domain-verification=PMmyc3J6
8-5H43Vybrpo3gmUrETM5JyvmpbAQ1_4_C
parkerici.org TXT 300 TXT:
logmein-verification-code=1c056d4f-e0ba-
4069-a484-3b85ac01c01b
parkerici.org TXT 300 TXT:
google-site-verification=s9AoM1MFNJBhJvU
gj5XNVIR5D9Z0XNOcm0E4Amtixmk
parkerici.org TXT 300 TXT: MS=ms14198102

Alexa Traffic Rank

Alexa Search Engine Traffic

Full WHOIS Lookup

Domain Name: PARKERICI.ORG
Registry Domain ID:
D177947426-LROR
Registrar WHOIS Server:
whois.name.com
Registrar URL: http://www.name.com
Updated
Date: 2019-12-10T17:05:39Z
Creation Date:
2015-11-06T17:20:36Z
Registry Expiry Date:
2023-11-06T17:20:36Z
Registrar Registration Expiration
Date:
Registrar: Name.com, Inc.
Registrar IANA ID:
625
Registrar Abuse Contact Email: [email protected]
Registrar
Abuse Contact Phone: +1.7203101849
Reseller:
Domain Status:
clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Domain Status:
clientUpdateProhibited
https://icann.org/epp#clientUpdateProhibited
Registrant
Organization: Domain Protection Services, Inc.
Registrant
State/Province: CO
Registrant Country: US
Name Server:
NS1DNS.NAME.COM
Name Server: NS2GLX.NAME.COM
Name Server:
NS4LRT.NAME.COM
Name Server: NS3JWX.NAME.COM
DNSSEC:
unsigned
URL of the ICANN Whois Inaccuracy Complaint Form
https://www.icann.org/wicf/)
>>> Last update of WHOIS database:
2020-01-26T22:21:16Z

Similarly Ranked Websites

Facebook Advertising | Sales Funnels | Business Strategy

- alliebjerk.com

Business and Marketing consultant Allie Bjerk specializes in marketing strategy, facebook ads and sales funnels for online entrepreneurs.

211,969   $ 43,740.00

国立大学法人 大分大学

- oita-u.ac.jp

大分大学の公式Web,Official Web Page of Oita University

211,970   $ 43,740.00

Access denied | poderjudicialcdmx.gob.mx used Cloudflare to...

- poderjudicialcdmx.gob.mx

211,972   $ 43,740.00

株式会社DONUTS

- donuts.ne.jp

株式会社DONUTSは、クラウドサービス事業・ジョブカン、ゲーム事業・単車の虎、D4DJなどの人気スマホゲーム、動画・ライブ配信事業・ミクチャ、医療事業・CLIUSの4領域を主軸としたWebサービスを展開しつつ、新たな事業領域にも挑戦を続けています。「10年・20年先にも価値を残せるサービスやコンテンツ」をテーマに、自己資本経営ならではのスピード感でさ...

211,973   $ 43,740.00

Governo de Timor-Leste

- timor-leste.gov.tl

Portal Oficial do Governo de Timor-Leste

211,975   $ 43,740.00
unsafe advertisement